A Novel Two-Gene Expression-Based Prognostic Score in Malignant Pleural Mesothelioma.

This is the first study to demonstrate good performance of only two-gene expression-based prognostic scores in MPM. Our initial approach for features selection allowed for an increased likelihood for the predictive value of the developed score, which we were also able to demonstrate.